Pfizer Inc. (NYSE:PFE) announced top-line results from a Phase 4 study

Pfizer Inc. (NYSE:PFE) announced top-line results from a Phase 4 study (CrisADe CARE 1) which showed that crisaborole ointment, 2%, was well-tolerated in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis (AD), also known as eczema. The data from the trial are supportive of the primary study objective to examine the safety of crisaborole ointment, 2%, in this patient population, and are consistent with previous clinical trial experience.1 Crisaborole ointment, 2%, is currently approved in select countries for mild to moderate AD in patients two years of age and older.

The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the PFE is 0.10%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the PFE is 74.90%.

Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that PFE. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Pfizer Inc. (NYSE:PFE) is -14.11%.

Institutional ownership is the amount of a Pfizer Inc. (NYSE:PFE)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the PFE is -2.20%.

See also  Best Drugstore Eye Cream: Find Out Which One to Buy

[finviz ticker=PFE]

U.S traded Pfizer Inc. (NYSE:PFE) stock gained 1.04% on Monday and when day-trade ended the stock finally concluded at $43.77 and number of shares that changed hands during the day are 21.65 Million. The number of shares PFE stock currently held by all its shareholders are 5574.05 and floated shares, the number of shares are available for trading in an open market on last trading day are 5557.96. The average volume of shares for 3 months is 22562.44 and PFE stock value has moved between $35.88 – 46.56 in last one year.

The Pfizer Inc. (NYSE:PFE)’s latest earnings date is 7/30/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Pfizer Inc. (NYSE:PFE) is 79.60% and the profit margin is 21.30% and the stock has gained 0.27% in 2019 to date.

U.S. traded shares of Pfizer Inc. (NYSE:PFE)’s monthly stock performance is 5.42%, the quarterly performance is 2.17%, the half year performance is calculated as 1.89%. The yearly performance of PFE is 20.38%.

The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Pfizer Inc. (NYSE:PFE) weekly volatility is measured as 1.71% and monthly volatility measured as 1.44%.

Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. PFE return on assets is 7.10%, the return on equity (ROE) of the Pfizer Inc. (NYSE:PFE) is 17.40%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and PFE return on investment is 10.20%.

The price to earnings ratio is 24.24, price to sales ratio is 4.53, and price to book ratio is 4.20, price to cash per share ration is 21.00, price to free cash flow is 44.90.

Analysts mean target price for Pfizer Inc. (NYSE:PFE) is $45.92 while analysts mean recommendation is 2.40. The current share price indicates that stock is -5.81% away from its one year high and is moving 21.58% ahead of its 52-week low. PFE’s distance from 20 day simple moving average is 1.75% and distance from 50-Day simple moving average is 4.87%.

Leave a Reply